（文章来源：证券日报） 证券日报网讯 12月12日，百联股份在互动平台回答投资者提问时表示，公司管理人员的任职均遵循 《公司法》《公司章程》等相关规定经法定程序选聘。公司将坚持聚焦主业，努力提升经营业绩水平， 以期为投资者创造更大价值。 ...

证券日报网讯12月12日，百联股份（600827）在互动平台回答投资者提问时表示，公司具备完善的项目 投资流程，请投资者以公司信息披露为准。 ...

（文章来源：证券日报） 证券日报网讯 12月12日，百联股份在互动平台回答投资者提问时表示，公司始终严格按照上交所的相 关规定履行信息披露义务，净资产及自有物业面积敬请参阅公司披露的定期报告。 ...

（文章来源：证券日报） 证券日报网讯 12月12日，百联股份在互动平台回答投资者提问时表示，公司高度重视投资者回报与信 任，持续以现金分红回报广大投资者。公司上市以来经历多轮吸收合并，不同的第三方交易软件对于融 资金额的计算口径不同。请投资者以公司信息披露为准。未来将持续推进标杆商业打造、重点项目转型 升级、供应链建设、提升营运质量、深化产融协同等工作。 ...

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

Company Overview - Bailian Co., Ltd. (SH 600827) announced its 18th meeting of the 10th Board of Directors held via teleconference on December 12, 2025, to review the proposal regarding the land reserve on Xitai Road [1] - As of the report, Bailian's market capitalization stands at 15.9 billion yuan [1] Revenue Composition - For the first half of 2025, Bailian's revenue composition is as follows: - Chain supermarket business accounts for 77.56% - Chain department store business accounts for 19.12% - Professional chain business accounts for 3.01% - Other businesses account for 0.31% [1]

股票简称：百联股份 百联 B 股 证券代码： 600827 900923 编号：临 2025-050 上海百联集团股份有限公司 关于土地收储的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、基本情况概述 三、其他说明 1 公司将持续跟进土地收储事项的后续进展情况，及时履行信息披露义务，敬请广 大投资者关注公司公告并注意投资风险。 特此公告。 上海百联集团股份有限公司董事会 2025 年 12 月 13 日 公司于2025年6月5日召开第十届董事会第十三次会议及2025年6月26日召开的2024 年年度股东大会审议通过《关于土地收储的议案》，同意公司与上海市杨浦区土地储备 中心（以下简称"杨浦区土储中心"）签订《上海市杨浦区国有土地收回补偿合同》， 对公司位于共青路435号、共青路295号、共青路310、210号三幅地块实施收储。具体 内容详见公司于2025年6月6日披露的《上海百联集团股份有限公司关于土地收储的公 告》（临2025-027）。公司于7月16日与杨浦区土储中心签订了《上海市杨浦区国有土地 收回补偿合 ...

| œ 11 3 2 1 1 15 201 100 1 | | --- | | 11.00 1 LL HR No. of Cattle. 2 P Carlos Concession 三重量 12 10.00 No. of each of 212 1000 11 1 1 11 1 No. of Acres, 国 ﺍﻟﻤﺴﺎ DARKET 13 DOGS 11.0 13 A 2000 11 Statute of 112 : September Sheet 1 2 2 12 2 1 FOL 600 10.00 100 86800 | 上海百联集团股份有限公司因共青路 435 号、共青路 295 号 以及共青路 310、210 号房地产收储涉及的对上海友谊集团 物流有限公司的补偿金额估值报告 上海财瑞资产评估有限公司 SHANGHAI CAI RUI ASSETS EVALUATION CO.,LTD 本报告仅供委托人为本次评估使用,使用权归 未经委托人许可不得向他人提供和公开其中部分 2025年10月20日 共 1 册/第 1 册 估值报告目录 沪财瑞业务字(2025) 第 5207 号 | 什值报告摘要 "… 第 ...

证券代码：600827 900923 证券简称：百联股份 百联 B 股 公告编号：2025-049 上海百联集团股份有限公司 关于共青路土地收储补偿方案暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 为配合上海市杨浦区土地储备中心（以下简称"杨浦区土储中心"）对上海百联集团 股份有限公司（以下简称"公司"）位于共青路 435 号、共青路 295 号、共青路 310、210 号三幅地块实施收储工作，上述地块由上海友谊集团物流有限公司（以下简称"友谊物流"） 租赁经营管理，公司拟与友谊物流签订《交地补偿协议》，向其支付补偿款共计人民币 102,967,400 元。友谊物流完成各地块土地交接后，公司将向其支付对应搬迁补偿款。 友谊物流为公司控股股东百联集团有限公司（以下简称"百联集团"）的全资四 级子公司，本次交易构成公司的关联交易。 截至本次交易，过去 12 个月，除日常关联交易及已披露的关联交易外，公司与百 联集团及其控制的其他企业未发生其他关联交易。 一、关联交易概述 （一）本次交易的基本情况 ...

证券代码： 600827 900923 编号：临 2025-048 股票简称：百联股份 百联 B 股 上海百联集团股份有限公司 二、《关于共青路土地收储补偿方案暨关联交易的议案》 表决结果：6 票同意，0 票反对，0 票弃权，3 票回避。 具体详见《关于共青路土地收储补偿方案暨关联交易的公告》（临 2025-049） 第十届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海百联集团股份有限公司（以下简称 "公司"）第十届董事会第十八次会议于 2025 年 12 月 12 日（周五）上午 10:30 以通讯会议方式召开。会议应到董事 9 名，实 到董事 9 名。会议符合《公司法》和《公司章程》的有关规定，会议经审议一致通过 以下议案： 一、《关于喜泰路土地收储的议案》 为积极响应上海市推进城市更新工作，上海市徐汇区土地储备中心拟对公司位于 喜泰路 233 号乙地块实施收储，涉及一幅土地及地上建（构）筑物、附属设施，建筑 面积合计 3,181 平方米，土地面积合计 2,027 平方米。公司拟与上海市徐 ...